Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Pharmaceuticals & Biotech
Create a narrative
BioGaia
OM:BIOG B Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
BioGaia
Popular
Undervalued
Overvalued
BioGaia
WA
Analyst Price Target
Consensus Narrative from 1 Analyst
Launch Of Gastrus PURE ACTION And Direct Operations Will Strengthen Future Prospects
Key Takeaways Direct market investments and internalizing operations in key regions enhance revenue potential by reducing reliance on distributors and capturing full retail margins. New products targeting niche markets along with strategic R&D investments drive future growth through innovation and unmet consumer needs.
View narrative
SEK 150.00
FV
18.3% undervalued
intrinsic discount
10.24%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Your Valuation for
BIOG B
BioGaia
Your Fair Value
SEK
Current Price
SEK 122.50
20.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
2b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 2.3b
Earnings SEK 564.1m
Advanced
Set as Fair Value